Chemoinformaics analysis of Phloretin-2- O-xylosyl glucoside
| Molecular Weight | 540.565 | nRot | 9 |
| Heavy Atom Molecular Weight | 508.309 | nRig | 25 |
| Exact Molecular Weight | 540.2 | nRing | 4 |
| Solubility: LogS | -3.969 | nHRing | 1 |
| Solubility: LogP | 3.341 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 3 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 18 |
| nHA | 10 | APOL | 77.7874 |
| nHD | 7 | BPOL | 36.4426 |
| QED | 0.198 |
| Synth | 4.174 |
| Natural Product Likeliness | 1.257 |
| NR-PPAR-gamma | 0.903 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.01 |
| HIA | 0.944 |
| CACO-2 | -6.043 |
| MDCK | 0.00000427 |
| BBB | 0.029 |
| PPB | 0.986161 |
| VDSS | 0.937 |
| FU | 0.0111389 |
| CYP1A2-inh | 0.515 |
| CYP1A2-sub | 0.091 |
| CYP2c19-inh | 0.268 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.545 |
| CYP2c9-sub | 0.744 |
| CYP2d6-inh | 0.935 |
| CYP2d6-sub | 0.795 |
| CYP3a4-inh | 0.604 |
| CYP3a4-sub | 0.178 |
| CL | 12.576 |
| T12 | 0.437 |
| hERG | 0.088 |
| Ames | 0.817 |
| ROA | 0.061 |
| SkinSen | 0.7 |
| Carcinogencity | 0.886 |
| EI | 0.018 |
| Respiratory | 0.038 |
| NR-Aromatase | 0.912 |
| Antiviral | Yes |
| Prediction | 0.865694 |